About the Authors
- Leslie Goo
-
Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America
- Laura A. VanBlargan
-
Affiliation Departments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America
- Kimberly A. Dowd
-
Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America
- Michael S. Diamond
-
Affiliation Departments of Medicine, Molecular Microbiology, Pathology & Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, United States of America
- Theodore C. Pierson
-
* E-mail: piersontc@mail.nih.gov
Affiliation Viral Pathogenesis Section, National Institutes of Health, Bethesda, MD, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceptualization: LG LAV KAD MSD TCP. Formal analysis: LG LAV. Funding acquisition: MSD TCP. Investigation: LG LAV. Methodology: LG LAV KAD MSD TCP. Supervision: MSD TCP. Validation: LG LAV MSD TCP. Visualization: LG. Writing – original draft: LG TCP. Writing – review & editing: LG LAV KAD MSD TCP.